Skip to main content
Loading market data...
ETF Cboe BZX USD

VanEck Morningstar SMID Moat ETF SMOT

Issuer: VanEck SEC registrant: VanEck ETF Trust Equity · US
Last price 39.61 USD Change: Up +0.65 Percent change: Up +1.67%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Net expense ratio
0.49%
Prospectus 1 Feb 2026
Net assets
$334.4M
As of 30 Jun 2026
Holdings
110
As of 30 Jun 2026
12-month distribution yield
1.26%
Yearly
Asset class
Equity
From holdings

VanEck Morningstar SMID Moat ETF (SMOT) is an exchange-traded fund listed on Cboe BZX in the United States, issued by VanEck. Its category is Equity · US (equity). Its last price was US$39.61 on 20 Oct 2026. Its net expense ratio is 0.49% a year, from its prospectus dated 1 Feb 2026. It reported net assets of US$334.35 million as of 30 Jun 2026. Its latest holdings report lists 110 holdings as of 30 Jun 2026. Over the last 12 months it paid distributions of US$0.50 a unit, a 12-month distribution yield of 1.26%, paid yearly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
0.49%
Net, after fee waivers or reimbursements
0.49%
Management fee
0.45%
Prospectus date
1 Feb 2026
Filed with the SEC
27 Jan 2026

Size and reporting

Net assets
$334,354,438
Total assets
$334,516,755
Holdings as of
30 Jun 2026
Report made public
26 Aug 2026 (57 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 110 positions, as of 30 Jun 2026. Weight is the percent of net assets the fund reported.

SMOT top holdings as of 30 Jun 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Acuity Inc US00508Y1029 1.70% $5.7M Equity (common) United States USD
2 Bio-Techne Corp US09073M1045 1.66% $5.6M Equity (common) United States USD
3 Masco Corp US5745991068 1.56% $5.2M Equity (common) United States USD
4 Biogen Inc US09062X1037 1.45% $4.9M Equity (common) United States USD
5 Royalty Pharma PLC GB00BMVP7Y09 1.45% $4.9M Equity (common) United Kingdom USD
6 Block Inc US8522341036 1.42% $4.8M Equity (common) United States USD
7 Corteva Inc US22052L1044 1.42% $4.8M Equity (common) United States USD
8 Amcor PLC JE00BV7DQ550 1.39% $4.6M Equity (common) Jersey USD
9 Gentex Corp US3719011096 1.39% $4.6M Equity (common) United States USD
10 Norwegian Cruise Line Holdings Ltd BMG667211046 1.38% $4.6M Equity (common) Bermuda USD
11 Carnival Corp Ltd BMG2004J1036 1.37% $4.6M Equity (common) Bermuda USD
12 IQVIA Holdings Inc US46266C1053 1.37% $4.6M Equity (common) United States USD
13 Ionis Pharmaceuticals Inc US4622221004 1.36% $4.6M Equity (common) United States USD
14 Airbnb Inc US0090661010 1.35% $4.5M Equity (common) United States USD
15 Brown-Forman Corp US1156372096 1.33% $4.4M Equity (common) United States USD
16 CNH Industrial NV NL0010545661 1.31% $4.4M Equity (common) Netherlands USD
17 Datadog Inc US23804L1035 1.29% $4.3M Equity (common) United States USD
18 TransUnion US89400J1079 1.29% $4.3M Equity (common) United States USD
19 Cigna Group/The US1255231003 1.27% $4.2M Equity (common) United States USD
20 DuPont de Nemours Inc US26614N2018 1.26% $4.2M Equity (common) United States USD
21 BioMarin Pharmaceutical Inc US09061G1013 1.24% $4.2M Equity (common) United States USD
22 Mondelez International Inc US6092071058 1.24% $4.2M Equity (common) United States USD
23 Stifel Financial Corp US8606301021 1.24% $4.2M Equity (common) United States USD
24 Lamb Weston Holdings Inc US5132721045 1.24% $4.1M Equity (common) United States USD
25 Kraft Heinz Co/The US5007541064 1.24% $4.1M Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 99.46%

Country

Country by weight
CountryWeightBar
United States 89.86%
Bermuda 2.75%
Netherlands 2.69%
United Kingdom 1.45%
Jersey 1.39%
Ireland 0.71%
Curaçao 0.60%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 99.46%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 19.67%
Industrials 19.39%
Consumer Discretionary 18.73%
Consumer Staples 8.22%
Finance 8.17%
Technology 7.77%
Energy 2.69%
Real Estate 2.23%
Basic Materials 1.59%
Utilities 0.67%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.4980
1 payment per unit
12-month yield
1.26%
Distributions only, not total return
Frequency
Yearly
From the gaps between ex-dates
Latest ex-date
22 Dec 2025

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.4980) ÷ latest price ($39.61) × 100 = 1.26%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (4 payments)
SMOT distributions per unit by ex-date
Ex-dateAmount per unit
22 Dec 2025$0.4980
23 Dec 2024$0.4080
18 Dec 2023$0.2060
19 Dec 2022$0.0640

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme